Cytokine release syndrome during ipilimumab and nivolumab therapy for renal-cell carcinoma successfully treated with tocilizumab: A case report

Ryo Nakagawa, Yushiro Takeuchi, Goshi Kitano, Makoto Kawase, Hiroki Hirabayashi, Yutaka Fujiwara, Takahiro Kojima

Open source

DOI
10.1007/s13691-026-00900-3
Published
2026-08-25
Container
International Cancer Conference Journal
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13691-026-00900-3,
  title = {Cytokine release syndrome during ipilimumab and nivolumab therapy for renal-cell carcinoma successfully treated with tocilizumab: A case report},
  author = {Ryo Nakagawa and Yushiro Takeuchi and Goshi Kitano and Makoto Kawase and Hiroki Hirabayashi and Yutaka Fujiwara and Takahiro Kojima},
  year = {2026},
  journal = {International Cancer Conference Journal},
  doi = {10.1007/s13691-026-00900-3},
  url = {https://doi.org/10.1007/s13691-026-00900-3}
}

RIS

TY  - JOUR
TI  - Cytokine release syndrome during ipilimumab and nivolumab therapy for renal-cell carcinoma successfully treated with tocilizumab: A case report
AU  - Ryo Nakagawa
AU  - Yushiro Takeuchi
AU  - Goshi Kitano
AU  - Makoto Kawase
AU  - Hiroki Hirabayashi
AU  - Yutaka Fujiwara
AU  - Takahiro Kojima
PY  - 2026
JO  - International Cancer Conference Journal
DO  - 10.1007/s13691-026-00900-3
UR  - https://doi.org/10.1007/s13691-026-00900-3
ER  - 

APA

Nakagawa, R., Takeuchi, Y., Kitano, G., Kawase, M., Hirabayashi, H., Fujiwara, Y., & Kojima, T. (2026). Cytokine release syndrome during ipilimumab and nivolumab therapy for renal-cell carcinoma successfully treated with tocilizumab: A case report. International Cancer Conference Journal. https://doi.org/10.1007/s13691-026-00900-3

Source records